Lymphopenia described in COVID-19, on the other hand, seems to be related to the virus’s ability to infect T cells depending on angiotensin-converting enzyme 2 (ACE2) receptors and CD147-spike protein [28]. This evidence concerns the gene BSG and lymphopenia.